| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 11, 2011Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries
MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
-
Apr 7, 2011New Structure Uniquely Positions Medtronic to Maintain Focus on Clinicians While Addressing the Needs of Cardiac and Vascular-focused Hospital Administrators
MINNEAPOLIS, Apr 07, 2011 (BUSINESS WIRE) -- Responding to the challenges hospitals face in the changing healthcare environment, as well as the increasing importance of the hospital administrator...
-
Apr 4, 2011Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers
NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
-
Apr 4, 2011Software Helps Users Identify Low and High Glucose Levels
MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
-
Apr 4, 2011Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes
MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...